2seventy Bio shares are trading higher after the company said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron.

2seventy bio, Inc. - Common Stock +2.50%

2seventy bio, Inc. - Common Stock

TSVT

4.51

+2.50%

2seventy Bio shares are trading higher after the company said it will focus exclusively on commercialization and development of Abecma and sell its R&D pipeline to Regeneron.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via